Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma.
about
Tumor-stroma IL-1β-IRAK4 feedforward circuitry drives tumor fibrosis, chemoresistance, and poor prognosis in pancreatic cancer.Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transitionThe Role of Toll-Like Receptor in Inflammation and Tumor Immunity
P2860
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Constitutive IRAK4 Activation ...... creatic Ductal Adenocarcinoma.
@en
Constitutive IRAK4 Activation ...... creatic Ductal Adenocarcinoma.
@nl
type
label
Constitutive IRAK4 Activation ...... creatic Ductal Adenocarcinoma.
@en
Constitutive IRAK4 Activation ...... creatic Ductal Adenocarcinoma.
@nl
prefLabel
Constitutive IRAK4 Activation ...... creatic Ductal Adenocarcinoma.
@en
Constitutive IRAK4 Activation ...... creatic Ductal Adenocarcinoma.
@nl
P2093
P2860
P1476
Constitutive IRAK4 Activation ...... ncreatic Ductal Adenocarcinoma
@en
P2093
Albert C Lockhart
Andrea Wang-Gillam
Brett L Knolhoff
Daoxiang Zhang
David G DeNardo
Hongmei Jiang
Marianna B Ruzinova
P2860
P304
P356
10.1158/1078-0432.CCR-16-1121
P407
P577
2016-10-04T00:00:00Z